Related Experiment Videos
Depression in radiation oncology patients: a preliminary evaluation
C Jenkins1, T J Carmody, A J Rush
1University of Texas, Southwestern Medical Center, Dallas, USA.
Journal of Affective Disorders
|August 26, 1998
Summary
Depression is not inevitable for cancer patients undergoing radiation therapy. Specific symptoms like cognitive issues and a history of depression can indicate higher risk, warranting further evaluation.
Area of Science:
- Oncology
- Psychiatry
- Psychosomatic Medicine
Background:
- Depression affects some cancer patients undergoing radiation therapy, but diagnosis is challenging due to overlapping symptoms with cancer and treatment side effects.
- Identifying depression in this population is crucial for effective patient care and management.
Purpose of the Study:
- To identify specific depressive symptoms that distinguish patients with depression from those without.
- To determine risk factors associated with depressive symptoms in radiation oncology outpatients.
Main Methods:
- Utilized the 30-item Inventory of Depressive Symptomatology-Self Report (IDS-SR) to assess 52 radiation oncology outpatients.
- Categorized patients into groups with (n=16) and without (n=36) depressive symptoms based on IDS-SR scores.
- Compared symptom profiles and risk factors between the two groups.
Main Results:
- Cognitive and endogenous depressive symptoms, unlike vegetative symptoms, effectively differentiated between patients with and without depression.
- A personal or family history of treated depression was a significant predictor of depressive symptoms.
- The number of radiation treatments received did not correlate with the presence of depressive symptoms.
Conclusions:
- Depressive symptoms are not an unavoidable consequence of cancer treatment.
- Patient self-reports of suicidal ideation, restlessness, or blunted mood response to positive events signal the need for comprehensive depression assessment.
- A history of treated depression (personal or familial) is linked to an elevated risk for developing depressive symptoms during cancer treatment.